Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT00326625 · COMPLETED

Trial details

NCT number: NCT00326625
Sponsor: Teva Pharmaceutical Industries, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2006-07-27
Primary completion: 2008-06-17
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.